Research Article

You have full text access to this OnlineOpen article

Racial differences in tumor stage and survival for colorectal cancer in an insured population†

  1. Chyke A. Doubeni MD, MPH1,2,‡,*,
  2. Terry S. Field DSc2,
  3. Diana S.M. Buist PhD3,
  4. Eli J. Korner PharmD, MPH4,
  5. Carol Bigelow PhD5,
  6. Lois Lamerato PhD6,
  7. Lisa Herrinton PhD7,
  8. Virginia P. Quinn PhD8,
  9. Gene Hart MS3,
  10. Mark C. Hornbrook PhD9,
  11. Jerry H. Gurwitz MD2,
  12. Edward H. Wagner MD, MPH3

Article first published online: 21 DEC 2006

DOI: 10.1002/cncr.22437

Issue

Cancer

Cancer

Volume 109, Issue 3, pages 612–620, 1 February 2007

Additional Information

How to Cite

Doubeni, C. A., Field, T. S., Buist, D. S.M., Korner, E. J., Bigelow, C., Lamerato, L., Herrinton, L., Quinn, V. P., Hart, G., Hornbrook, M. C., Gurwitz, J. H. and Wagner, E. H. (2007), Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer, 109: 612–620. doi: 10.1002/cncr.22437

Author Information

  1. 1

    Department of Family Medicine and Community Health, University of Massachusetts, Worcester, Massachusetts

  2. 2

    Meyers Primary Care Institute; University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, Massachusetts

  3. 3

    Group Health Center for Health Studies, Kaiser Permanente Southern California, Pasadena, California

  4. 4

    Clinical Research Unit, Kaiser Permanente, Aurora, Colorado

  5. 5

    Program in Biostatistics and Epidemiology, School of Public Health, University of Massachusetts, Amherst, Massachusetts

  6. 6

    Center for Health Services Research, Henry Ford Health System, Detroit, Michigan

  7. 7

    Division of Research, Kaiser Permanente Northern California, Oakland, California

  8. 8

    Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, California

  9. 9

    Center for Health Research, Northwest/Hawaii, Kaiser Permanente Northwest, Portland, Oregon

  1. ‡

    Fax: (508) 856-1212

*Department of Family Medicine and Community Health, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655

  1. †

    This research was made possible by the cooperation of the participating Cancer Research Network members. We are particularly grateful to Donald J. Bachman, MS; Jennifer Ellis, MSPH; Hassan Fouayzi, MS; Rick Krajenta; Liyan Liu, MSPH; Janis Yao, MS; and Fagen Xie, PhD, whose collective work in building the Cancer Research Network's Virtual Data Warehouse made this research project possible.

Publication History

  1. Issue published online: 19 JAN 2007
  2. Article first published online: 21 DEC 2006
  3. Manuscript Accepted: 9 NOV 2006
  4. Manuscript Revised: 6 NOV 2006
  5. Manuscript Received: 24 AUG 2006

Funded by

  • Funding from the National Cancer Institute to the Cancer Research Network. Grant Number: U19 CA079689
  • National Cancer Institute to the Cancer Research Network. Grant Number: U19 CA079689-06
  • American Cancer Society. Grant Number: CRTG-03-024-01-CCE

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (156K)

REFERENCES

  • 1
    American Cancer Society. Cancer Facts and Figures 2006. Atlanta, Ga: American Cancer Society; 2006.
  • 2
    Stryker SJ,Wolff BG,Culp CE,Libbe SD,Ilstrup DM,MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987; 93: 1009–1013.
  • 3
    Vogelstein B,Fearon ER,Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988; 319: 525–532.
  • 4
    Winawer SJ,Zauber AG,Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy.The National Polyp Study Workgroup. N Engl J Med. 1993; 329: 1977–1981.
  • 5
    American Cancer Society. Colorectal Cancer Facts and Figures- Special Edition 2005. Atlanta: American Cancer Society; 2005: 1–24.
  • 6
    Chien C,Morimoto LM,Tom J,Li CI. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005; 104: 629–639.
    Direct Link:
  • 7
    Clegg LX,Li FP,Hankey BF,Chu K,Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002; 162: 1985–1993.
  • 8
    Jemal A,Clegg LX,Ward E, et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 2004; 101: 3–27.
    Direct Link:
  • 9
    Govindarajan R,Shah RV,Erkman LG,Hutchins LF. Racial differences in the outcome of patients with colorectal carcinoma. Cancer. 2003; 97: 493–498.
    Direct Link:
  • 10
    Mayberry RM,Coates RJ,Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995; 87: 1686–1693.
  • 11
    Gordon NP,Rundall TG,Parker L. Type of health care coverage and the likelihood of being screened for cancer. Med Care. 1998; 36: 636–645.
  • 12
    Polite BN,Dignam JJ,Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006; 24: 2179–2187.
  • 13
    Shavers VL,Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334–357.
  • 14
    Brown R,Bergeron J,Clement DG,Hill TW,Retchin S. Does Managed Care Work for Medicare? An Evaluation of the Medicare Risk Program for HMOs. Princeton, NJ: Mathematica Policy Research; 1993.
  • 15
    Bernstein AB,Thompson GB,Harlan LC. Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey. Med Care. 1991; 29: 196–209.
  • 16
    Patrick DL,Grembowski D,Durham M, et al. Cost and outcomes of Medicare reimbursement for HMO preventive services. Health Care Finance Rev. 1999; 20: 25–43.
  • 17
    Potosky AL,Breen N,Graubard BI,Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care. 1998; 36: 257–270.
  • 18
    Zapka JG,Puleo E,Vickers-Lahti M,Luckmann R. Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002; 23: 28–35.
  • 19
    Riley GF,Potosky AL,Lubitz JD,Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health. 1994; 84: 1598–1604.
  • 20
    Field TS,Buist DS,Doubeni C, et al. Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr. 2005; 2005: 88–95.
  • 21
    Hornbrook MC,Hart G,Ellis JL, et al. Building a virtual cancer research organization. J Natl Cancer Inst Monogr. 2005; 2005: 12–25.
  • 22
    National Cancer Institute. Introduction to Summary Staging. In: YoungJLJ, RoffersSD, RiesLAG, FritzAG, HurlbutAA, eds. SEER Summary Staging Manual-2000: Codes and Coding Instructions. National Cancer Institute, NIH pub. no. 01–4969. 2006 vol. Bethesda, Md: National Cancer Institute; 2001: 2–15. Available at URL: http://seer.cancer.gov./tools/ssm/ Accessed December 11, 2006.
  • 23
    Hoel DG,Ron E,Carter R,Mabuchi K. Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst. 1993; 85: 1063–1068.
  • 24
    Deyo RA,Cherkin DC,Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613–619.
  • 25
    Hosmer DW,Lemeshow S. Special topics. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000: 260–351.
  • 26
    Roetzheim RG,Pal N,Gonzalez EC,Ferrante JM,Van Durme DJ,Krischer JP. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000; 90: 1746–1754.
  • 27
    Byers T,Levin B,Rothenberger D,Dodd GD,Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997.American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin. 1997; 47: 154–160.
    Direct Link:
  • 28
    Cooper GS,Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004; 100: 418–424.
    Direct Link:
  • 29
    Cooper GS,Payes JD. Receipt of colorectal testing prior to colorectal carcinoma diagnosis. Cancer. 2005; 103: 696–701.
    Direct Link:
  • 30
    Rex DK,Rawl SM,Rabeneck L,Rex EK,Hamilton F. Colorectal cancer in African Americans. Rev Gastroenterol Disord. 2004; 4: 60–65.
  • 31
    Ferris TG,Kuhlthau K,Ausiello J,Perrin J,Kahn R. Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma. Med Care. 2006; 44: 81–86.
  • 32
    Groeneveld PW,Laufer SB,Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989–2000. Med Care. 2005; 43: 320–329.
  • 33
    Dominitz JA,Samsa GP,Landsman P,Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998; 82: 2312–2320.
    Direct Link:
  • 34
    Rabeneck L,Souchek J,El-Serag HB. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol. 2003; 98: 1186–1192.
    Direct Link:
  • 35
    Dignam JJ,Colangelo L,Tian W, et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst. 1999; 91: 1933–1940.
  • 36
    Dignam JJ,Ye Y,Colangelo L, et al. Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials. J Clin Oncol. 2003; 21: 413–420.
  • 37
    McCollum AD,Catalano PJ,Haller DG, et al. Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst. 2002; 94: 1160–1167.
  • 38
    Kirsner RS,Ma F,Fleming L, et al. The effect of Medicare health care delivery systems on survival for patients with breast and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 769–773.
  • 39
    Merrill RM,Brown ML,Potosky AL, et al. Survival and treatment for colorectal cancer Medicare patients in two group/staff health maintenance organizations and the fee-for-service setting. Med Care Res Rev. 1999; 56: 177–196.
  • 40
    Rogers SO,Ray WA,Smalley WE. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? [United States]. Cancer Causes Control. 2004; 15: 193–199.
  • 41
    Institute of Medicine. Insuring America's health: principles and recommendations. Acad Emerg Med. 2004; 11: 418–422.
    Direct Link:
  • 42
    Schwartz KL,Crossley-May H,Vigneau FD,Brown K,Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control. 2003; 14: 761–766.
  • 43
    Johnson RL,Roter D,Powe NR,Cooper LA. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health. 2004; 94: 2084–2090.
  • 44
    Klabunde CN,Vernon SW,Nadel MR,Breen N,Seeff LC,Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care. 2005; 43: 939–944.
  • 45
    Wee CC,McCarthy EP,Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005; 41: 23–29.
  • 46
    Ayanian JZ,Zaslavsky AM,Guadagnoli E, et al. Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol. 2005; 23: 6576–6586.
  • 47
    LaVeist TA,Nickerson KJ,Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev. 2000; 57( suppl 1): 146–161.
  • 48
    Shi L. Experience of primary care by racial and ethnic groups in the United States. Med Care. 1999; 37: 1068–1077.
  • 49
    Weinick RM,Zuvekas SH. Experience of primary care by racial and ethnic groups. Med Care. 2000; 38: 447–448.
  • 50
    Swanson RS,Compton CC,Stewart AK,Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003; 10: 65–71.
View Full Article (HTML) Get PDF (156K)